Status:

COMPLETED

Aldosterone and Vascular Disease in Diabetes Mellitus

Lead Sponsor:

Brigham and Women's Hospital

Collaborating Sponsors:

National Institutes of Health (NIH)

Conditions:

Diabetes Mellitus

Endothelial Dysfunction

Eligibility:

All Genders

21-64 years

Phase:

NA

Brief Summary

Specific aims for this proposal are to determine in patients with diabetes mellitus the effects of an aldosterone receptor antagonist on: 1. Coronary microvascular function assessed by MRI perfusion ...

Detailed Description

Recent human and animal studies suggest that activation of the mineralocorticoid receptor (MR) by aldosterone, the final product of the renin-angiotensin-aldosterone system, causes microvascular damag...

Eligibility Criteria

Inclusion

  • Men and women (21-64 years old) with type 1 or type 2 diabetes mellitus and albuminuria (over 30 mg/g creatinine).

Exclusion

  • Exclusion criteria include: (1) subjects without hypertension who have baseline systolic blood pressure \<100 mmHg, (2) severe hypertension (blood pressure must be well-controlled on 3 antihypertensive agents or \<150/100 mmHg on £2 antihypertensive agents), (3) ischemic changes on resting electrocardiogram, (4) clinical evidence of heart disease, cerebrovascular or peripheral vascular disease, (5) significant cardiac arrhythmias, (6) aortic stenosis, (7) 2nd or 3rd degree atrio-ventricular block, sinus node disease, or symptomatic bradycardia, (8) bronchospastic lung disease with active wheezing, (9) known hypersensitivity to any of the study drugs, (10) any contraindication to MRI, (11) serum creatinine ³ 1.5 mg/dL, (12) serum potassium ³ 5.0 mmol/L, (13) current smoker, (14) Serum transaminases greater than twice the upper limit of normal, (15) a history of gout, (16) pregnancy, and (17) other active medical problems detected by examination or laboratory testing.

Key Trial Info

Start Date :

August 1 2003

Trial Type :

INTERVENTIONAL

Allocation :

ACTUAL

End Date :

March 1 2006

Estimated Enrollment :

46 Patients enrolled

Trial Details

Trial ID

NCT00214825

Start Date

August 1 2003

End Date

March 1 2006

Last Update

January 3 2008

Active Locations (1)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 1 (1 locations)

1

Brigham and Women's Hospital

Boston, Massachusetts, United States, 02115